Date
Results for
"[search-keyword]"
Sponsor content
1 result(s) found, displaying 1 to 1
-
Nov-2023Prescription medicine evaluationActive ingredient: Pertussis filamentous haemagglutinin, recombinant Pertussis toxin.
Technovalia Pty Ltd
Regulatory activities for this sponsor.